Analyst Ratings for Infinity Pharmaceutical (INFI)

INFI Rating Summary

  |   Expand Research on INFI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.5 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/24/2023 Piper Sandler Edward Tenthoff Downgrade Neutral
(Overweight)		 0.30
(3.00)		 0.55
(0.04)		 -92.73% Details
11/15/2022 B.Riley Pharm Patel Downgrade Neutral
(Buy)		 1.50
(N/A)		 0.74
(0.04)		 -94.59% Details